The Cryptosporidiosis Therapeutics Advocacy Group (CTAG)
The Cryptosporidium Therapeutics Advocacy Group (CTAG) is a global organization dedicated to finding new solutions to combat the disease and has been working to secure the disease’s addition to the NTD list.
CTAG authors: Timothy A. Rapuano, MS, clinical trials project manager at the University of Washington Molecular Virology Laboratory; and president of the Organization of Regulatory and Clinical Associates (ORCA).
Nede A. Ovbiebo is a recent graduate of the University of Washington, with bachelor’s degrees in public health-global health and biochemistry.
Allison M.L. Crawford, MSc, research scientist at the University of Washington Molecular Virology Laboratory.
Beatrice Amadi, MD, MMed. Paed., PG Dip. Paed, gastroenterologist, co-director and a researcher at Tropical Gastroenterology & Nutrition Research Group;) and until recently, consultant pediatrician in charge of the Malnutrition Ward at the Children’s Hospital, University Teaching Hospitals, Ministry of Health; and honorary lecturer, School of Medicine, University of Zambia.
Wesley C. Van Voorhis, MD, PhD, CTAG leader; director of the Center for Emerging and Re-emerging Infectious Diseases (CERID); and professor at the University of Washington.